Role of iron in tumor cell protection from the pro-apoptotic effect of nitric oxide

Cancer Research

Volumn 61, Issue 13, 2001, Pages 5289-5294

  Feger, Fredéric ^a   Ferry Dumazet, Héléne ^b   Matsuda, Maria ^b   Bordenave, Joëlle ^a   Dupouy, Maryse ^b   Nussler, Andreas K ^c   Arock, Michel ^a   Devevey, Lionel ^a   Nafziger, Joëlle ^a   Guillosson, Jean Jacques ^a   Reiffers, Josy ^b   Mossalayi, M Djavad ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c Berlin University   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 (2 AMINOETHYL) N (2 AMMONIOETHYL)AMINO]DIAZIN 1 IUM 1,2 DIOLATE; CYCLIC GMP; DEFEROXAMINE; IRON; N ACETYL S NITROSOPENICILLAMINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; NITROSO DERIVATIVE; PEROXYNITRITE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER RESISTANCE; CELL PROTECTION; CELL STRAIN; CONTROLLED STUDY; DRUG SENSITIVITY; EPITHELIUM CELL; HUMAN; HUMAN CELL; LIVER TUMOR; LUNG TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; SKIN TUMOR; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; FERRICYANIDES; HUMANS; IRON; NEOPLASMS; NITRIC OXIDE; NITRIC OXIDE DONORS; PENICILLAMINE; S-NITROSO-N-ACETYLPENICILLAMINE; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0035394725     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Nitric oxide-cyclic GMP signal transduction system
2. Molecular mechanisms and therapeutic strategies related to nitric oxide
3. Nitric oxide and macrophage function
4. Nitric oxide production and nitric oxide synthase type 2 expression by human mononuclear phagocytes: A review
5. Nitric oxide. A macrophage product responsible for cytostasis and respiratory, inhibition in tumor target cells
6. Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism
7. Apoptotic death of human leukemic cells induced by vascular cells expressing nitric oxide synthase in response to γ-interferon and tumor necrosis factor-α
8. Growth arrest and terminal differentiation of leukemic myelomonocytic cells induced through ligation of surface CD23 antigen
9. Therapy of human pancreatic carcinoma implants by irinotecan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages
10. Excessive production of nitric oxide in rat solid tumor and its implication in rapid tumor growth
11. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Bag virus reactivation
12. Nitric oxide prevents oxidative damage produced by tert-butyl hydroperoxide in erythroleukemia cells via nitrosylation of heme and non-heme iron. Electron paramagnetic resonance evidence
13. Nitric oxide inhibits tumor necrosis factor-α-induced apoptosis by reducing the generation of ceramide
14. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity
15. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes
16. Nitric oxide inhibits apoptosis via AP-1-dependent CD95L transactivation
17. Iron-induced carcinogenesis: The role of redox regulation
18. Iron, asbestos, and carcinogenicity
19. Generation of EPR-detectable nitrosyl-iron complexes in tumor target cells co-cultured with activated macrophages
20. Induction of iron-derived EPR signals in murine cancers by nitric oxide. Evidence for multiple intracellular targets
21. Isolation and characterization of a human hepatic epithelial-like cell line (AKN-1) from a normal liver
22. Involvement of the cAMP and nitric oxide pathway in the IgE-dependent activation of normal human keratinocytes
23. Quantitative analysis
24. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein
25. cGMP mediates the vascular and platelet actions of nitric oxide: Confirmation using an inhibitor of the soluble guanylyl cyclase
26. Poly (ADP-ribose) polymerase, nitric oxide and cell death
27. Critical role of nitric oxide during the apoptosis of peripheral blood leukocytes from patients with AIDS
28. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma
29. + Chinese hamster V79 cells
30. Dinitrosyl iron complexes with thiol-containing ligands and S-nitroso-D-L-penicillamine as inductors of heat shock protein synthesis in H35 hepatoma cells
31. S-nitrosoglutathione is cleaved by the thioredoxin system with liberation of glutathione and redox regulating nitric oxide
32. 2+ exchanger in C6 glioma cells
33. Interferon (IFN)-α activation of human blood mononuclear cells in vitro and in vivo for nitric oxide synthase (NOS) type 2 mRNA and protein expression: Possible relationship of induced NOS2 to the anti-hepatitis C effects of IFN-α in vivo
34. Distribution of iron in the liver predicts the response of chronic hepatitis C infection to interferon therapy
35. Hepatic iron stainings in chronic hepatitis C patients with low HCV RNA levels: A predictive marker for IFN therapy
36. Cellular non-heme iron content is a determinant of nitric oxide-mediated apoptosis, necrosis, and caspase inhibition
37. Inhibition of N-myc expression and induction of apoptosis by iron chelation in human neuroblastoma cells
38. Development of clinical methods of iron deprivation for suppression of neoplastic and infectious diseases